Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2022 | Genomic tests available to patients with CLL at tertiary hospitals

Lukas Smolej, MD, PhD, Faculty of Medicine and University Hospital, Charles University, Hradec Králové, Czech Republic, highlights genomic tests available to patients with chronic lymphocytic leukemia (CLL) at a tertiary hospital, including tests for IgHV and TP53 mutational status. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.